Statistical analysis of VE-cadherin and CD45 expression in 6- to 23-week-old human embryonic and fetal livers
| Developmental stage, weeks of gestation . | No. of embryos per stage . | % VE-cadherin+CD45− cells ± SD (range) . | % VE-cadherin+CD45+ cells ± SD (range) . | % VE-cadherin−CD45+ cells ± SD (range) . |
|---|---|---|---|---|
| 6 | 1 | 0.99 | 0.63 | 5.22 |
| 6.9 | 1 | 1.39 | 0.57 | 5.47 |
| 7 to 7.4 | 14 | 1.18 ± 0.18 (0.92-1.38) | 0.48 ± 0.069 (0.36-0.54) | 4.51 ± 0.66 (4.04-5.65) |
| 7.5 to 7.9 | 16 | 1.43 ± 0.35 (0.78-1.78) | 0.34 ± 0.06 (0.2-0.44) | 4.67 ± 0.53 (3.99-5.81) |
| 8 to 8.4 | 6 | 1.14 ± 0.23 (0.78-1.44) | 0.12 ± 0.04 (0.06-0.18) | 5.09 ± 0.86 (3.73-6.23) |
| 9 | 1 | 0.86 | 0.06 | 3.89 |
| 10 | 1 | 0.2 | 0.03 | 3.5 |
| 23 | 1 | 0.24 | 0 | 2.89 |
| Developmental stage, weeks of gestation . | No. of embryos per stage . | % VE-cadherin+CD45− cells ± SD (range) . | % VE-cadherin+CD45+ cells ± SD (range) . | % VE-cadherin−CD45+ cells ± SD (range) . |
|---|---|---|---|---|
| 6 | 1 | 0.99 | 0.63 | 5.22 |
| 6.9 | 1 | 1.39 | 0.57 | 5.47 |
| 7 to 7.4 | 14 | 1.18 ± 0.18 (0.92-1.38) | 0.48 ± 0.069 (0.36-0.54) | 4.51 ± 0.66 (4.04-5.65) |
| 7.5 to 7.9 | 16 | 1.43 ± 0.35 (0.78-1.78) | 0.34 ± 0.06 (0.2-0.44) | 4.67 ± 0.53 (3.99-5.81) |
| 8 to 8.4 | 6 | 1.14 ± 0.23 (0.78-1.44) | 0.12 ± 0.04 (0.06-0.18) | 5.09 ± 0.86 (3.73-6.23) |
| 9 | 1 | 0.86 | 0.06 | 3.89 |
| 10 | 1 | 0.2 | 0.03 | 3.5 |
| 23 | 1 | 0.24 | 0 | 2.89 |
Percent phenotype frequency ± SD (range) for endothelial (VE-cadherin+CD45−), hematopoietic (VE-cadherin−CD45+) and DP (VE-cadherin+CD45+) cell populations are reported as a percentage of total viable cells. SD, standard deviation.